Balanced news tone
News Sentiment
TECX sentiment intelligence
Tectonic Therapeutic, Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
79/100 classification confidence.
directly relevant articles
high-authority source matches
-9.4% over one week, +13.5% over four weeks, trend active, and materially above fair value.
How (TECX) Movements Inform Risk Allocation Models
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 Jul 2026 12:30
- Source
- Market source
How (TECX) Movements Inform Risk Allocation Models
This article analyzes Avrobio Inc. (NASDAQ: TECX) movements to inform risk allocation models, noting weak near-term sentiment despite strong mid and long-term signals. It outlines institutional trading strategies including long, breakout, and short setups, and provides multi-time
- Tone
- Negative 39/100
- Event
- Market update
- Published
- 12 Jul 2026 03:39
- Source
- Stock Traders Daily
Here's Why We're Not Too Worried About Tectonic Therapeutic's (NASDAQ:TECX) Cash Burn Situation
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 09 Jul 2026 14:16
- Source
- Moomoo
We're Hopeful That Tectonic Therapeutic (NASDAQ:TECX) Will Use Its Cash Wisely
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 09 Jul 2026 11:12
- Source
- simplywall.st
If You Invested $1,000 in Tectonic Therapeutic Inc (TECX)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jul 2026 05:16
- Source
- Stock Titan
Tectonic Therapeutic (TECX) CSO exercises options and sells 172 shares under 10b5-1 plan
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jul 2026 07:00
- Source
- Stock Titan
Trading Systems Reacting to (TECX) Volatility
This article analyzes Avrobio Inc. (NASDAQ: TECX) stock, highlighting strong sentiment across all horizons and a mid-channel oscillation pattern. It details institutional trading strategies, including position trading, momentum breakout, and risk hedging, with specific entry, tar
- Tone
- Positive 72/100
- Event
- Market update
- Published
- 01 Jul 2026 02:06
- Source
- Stock Traders Daily
[144] Tectonic Therapeutic, Inc. SEC Filing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 07:00
- Source
- Stock Titan
Tectonic Therapeutic (TECX) CEO logs routine tax withholding on vested RSUs
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Jun 2026 07:00
- Source
- Stock Titan
Tectonic Therapeutic Completes Enrollment in in Phase 2 Trial of TX45
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 20:30
- Source
- MT Newswires
Tectonic Therapeutic Completes Enrollment in TX45 APEX Phase 2 Clinical Trial in PH-HFpEF Patients
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 20:01
- Source
- GlobeNewswire
(TECX) and the Role of Price-Sensitive Allocations
This article provides a quantitative analysis of Avrobio Inc. (NASDAQ: TECX), offering neutral near- and mid-term readings but a long-term positive bias. It details institutional trading strategies including long, breakout, and short positions, along with multi-timeframe signal a
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jun 2026 23:46
- Source
- Stock Traders Daily
Responsive Playbooks and the TECX Inflection
This article analyzes Avrobio Inc. (NASDAQ: TECX), identifying a strong near-term sentiment while expecting mid-term neutrality to shift towards a long-term positive bias. It highlights a 76.0:1 risk-reward setup targeting a 22.3% gain with minimal risk and provides three distinc
- Tone
- Positive 73/100
- Event
- Market update
- Published
- 28 May 2026 22:16
- Source
- Stock Traders Daily
Tectonic Therapeutic Shares Rise After Raymond James Upgrade
- Tone
- Positive 58/100
- Event
- Analyst action
- Published
- 26 May 2026 18:51
- Source
- MT Newswires
Raymond James Upgrades Tectonic Therapeutic to Strong Buy From Outperform, Adjusts PT to $81 From $76
- Tone
- Positive 74/100
- Event
- Analyst action
- Published
- 26 May 2026 09:29
- Source
- MT Newswires
Tectonic Therapeutics: Currently In A Catalyst Vacuum (NASDAQ:TECX)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 May 2026 07:00
- Source
- Seeking Alpha
Understanding the Setup: (TECX) and Scalable Risk
This article analyzes Avrobio Inc. (NASDAQ: TECX), noting a neutral near and mid-term outlook but a positive long-term bias. It highlights a significant 78.0:1 risk-reward setup, targeting a 23.7% gain against 0.3% risk, and provides three AI-generated trading strategies (Positio
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 17 May 2026 21:08
- Source
- Stock Traders Daily
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
Tectonic Therapeutic Announces First Quarter 2026 Financial Results and Recent Business Highlights
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 May 2026 07:00
- Source
- GlobeNewswire
The Technical Signals Behind (TECX) That Institutions Follow
This article from Stock Traders Daily discusses the technical signals for Avrobio Inc. (NASDAQ: TECX), highlighting a near-term strong sentiment transitioning to mid-term neutrality and long-term positive bias. It presents three AI-generated institutional trading strategies—Posit
- Tone
- Positive 70/100
- Event
- Market update
- Published
- 06 May 2026 20:09
- Source
- Stock Traders Daily
Tectonic Therapeutic (NASDAQ:TECX) Is In A Good Position To Deliver On Growth Plans
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 01 May 2026 07:00
- Source
- Market source
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Tectonic Therapeutic Appoints Jessica Chutter to Board of Directors
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Apr 2026 07:00
- Source
- GlobeNewswire
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
Tectonic Therapeutic Stock: A $1B+ Opportunity Hinges On Upcoming Phase 2 (NASDAQ:TECX)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Apr 2026 07:00
- Source
- Seeking Alpha
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Mar 2026 07:00
- Source
- TradingView
Unveiling Bumps: How Tectonic Therapeutic’s Recent Moves Affect the Market
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 Mar 2026 08:00
- Source
- timothysykes.com